KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) Revenue (2017 - 2025)

Historic Revenue for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $7.4 million.

  • Bionano Genomics' Revenue rose 2130.74% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.7 million, marking a year-over-year decrease of 1384.17%. This contributed to the annual value of $30.8 million for FY2024, which is 1478.57% down from last year.
  • Latest data reveals that Bionano Genomics reported Revenue of $7.4 million as of Q3 2025, which was up 2130.74% from $6.7 million recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Revenue registered a high of $10.7 million during Q4 2023, and its lowest value of $3.2 million during Q1 2021.
  • Moreover, its 5-year median value for Revenue was $7.2 million (2022), whereas its average is $7.0 million.
  • In the last 5 years, Bionano Genomics' Revenue soared by 22622.67% in 2021 and then crashed by 3482.51% in 2024.
  • Quarter analysis of 5 years shows Bionano Genomics' Revenue stood at $6.3 million in 2021, then surged by 30.36% to $8.2 million in 2022, then surged by 30.51% to $10.7 million in 2023, then decreased by 23.86% to $8.2 million in 2024, then decreased by 9.75% to $7.4 million in 2025.
  • Its Revenue was $7.4 million in Q3 2025, compared to $6.7 million in Q2 2025 and $6.5 million in Q1 2025.